Eterna Therapeutics Inc.

NASDAQ (USD): Eterna Therapeutics Inc. (ERNA)

Last Price

0.307

Today's Change

+0.019 (6.59%)

Day's Change

0.284 - 0.323

Trading Volume

817,424

Overview

Market Cap

15 Million

Shares Outstanding

51 Million

Avg Volume

11,364,596

Avg Price (50 Days)

0.35

Avg Price (200 Days)

1.25

PE Ratio

-0.04

EPS

-8.31

Earnings Announcement

12-Mar-2025

Previous Close

0.29

Open

0.31

Day's Range

0.2839 - 0.3231

Year Range

0.22 - 2.63

Trading Volume

818,895

Price Change Highlight

1 Day Change

6.74%

5 Day Change

9.71%

1 Month Change

-27.24%

3 Month Change

-63.21%

6 Month Change

-82.14%

Ytd Change

-16.75%

1 Year Change

-81.27%

3 Year Change

-99.33%

5 Year Change

-99.64%

10 Year Change

-99.97%

Max Change

-100.00%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. Brooklyn ImmunoTherapeutics, Inc. is based in Brooklyn, New York.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment